Published in J Clin Endocrinol Metab on December 01, 1996
Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. EMBO J (1999) 1.78
The syndromes of reduced sensitivity to thyroid hormone. Biochim Biophys Acta (2012) 1.35
Homozygous thyroid hormone receptor β-gene mutations in resistance to thyroid hormone: three new cases and review of the literature. J Clin Endocrinol Metab (2012) 1.14
Thyroid hormone receptors and resistance to thyroid hormone disorders. Nat Rev Endocrinol (2014) 1.06
Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. J Clin Endocrinol Metab (2014) 0.97
Molecular analysis of the androgen-receptor gene in a family with receptor-positive partial androgen insensitivity: an unusual type of intronic mutation. Am J Hum Genet (1997) 0.93
Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. Thyroid (2014) 0.81
Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. Eur Thyroid J (2014) 0.76
A Case of Resistance to Thyroid Hormone with Chronic Thyroiditis: Discovery of a Novel Mutation (I54V). Case Rep Endocrinol (2011) 0.75
Thyroid hormone action beyond the receptor. J Clin Endocrinol Metab (1996) 0.75
Defects of Thyroid Hormone Synthesis and Action. Endocrinol Metab Clin North Am (2017) 0.75
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Calcium channels activated by hydrogen peroxide mediate abscisic acid signalling in guard cells. Nature (2000) 7.73
Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science (1999) 6.77
Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons. Cell (2001) 6.00
Frequent allelic loss of the RB, D13S319 and D13S25 locus in myeloid malignancies with deletion/translocation at 13q14 of chromosome 13, but not in lymphoid malignancies. Leukemia (1999) 5.02
Clinical evaluation of cerebral oxygen balance during cardiopulmonary bypass: on-line continuous monitoring of jugular venous oxyhemoglobin saturation. Anesth Analg (1992) 3.72
Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med (1988) 3.50
Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell (2001) 3.49
Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab (2001) 3.43
Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A (1997) 3.37
Isolation of mutants of Schizosaccharomyces pombe unable to synthesize cadystin, small cadmium-binding peptides. Biochem Biophys Res Commun (1988) 3.09
Postnatal synaptic potentiation: delivery of GluR4-containing AMPA receptors by spontaneous activity. Nat Neurosci (2000) 2.95
Arabidopsis abi1-1 and abi2-1 phosphatase mutations reduce abscisic acid-induced cytoplasmic calcium rises in guard cells. Plant Cell (1999) 2.85
Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut (2003) 2.71
The Pumilio RNA-binding domain is also a translational regulator. Mol Cell (1998) 2.68
Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein. Genes Dev (2000) 2.65
Two-photon imaging in living brain slices. Methods (1999) 2.53
Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc Natl Acad Sci U S A (2000) 2.49
Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab (1967) 2.47
Improved radioimmunoassay for measurement of mouse thyrotropin in serum: strain differences in thyrotropin concentration and thyrotroph sensitivity to thyroid hormone. Thyroid (1999) 2.44
Identification of amino acid sequences in the integrin beta 1 cytoplasmic domain implicated in cytoskeletal association. J Cell Biol (1992) 2.44
Natural history of polypoid lesions in the gall bladder. Gut (1996) 2.33
Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature (1991) 2.26
DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet (1997) 2.18
Template activities of the phi X-174 replicative allomorphic deoxyribonucleic acids. Biochemistry (1971) 2.07
Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science (1997) 2.06
Control of rectification and permeation by two distinct sites after the second transmembrane region in Kir2.1 K+ channel. J Physiol (2001) 2.05
Use of the AO hook-plate for treatment of unstable fractures of the distal clavicle. Arch Orthop Trauma Surg (2007) 2.03
PTEN mutations in gliomas and glioneuronal tumors. Oncogene (1998) 2.01
LTP mechanisms: from silence to four-lane traffic. Curr Opin Neurobiol (2000) 2.00
Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid diseases. Clin Endocrinol (Oxf) (1976) 1.92
Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet (1998) 1.91
Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine. J Exp Med (1986) 1.89
Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. Proc Natl Acad Sci U S A (1989) 1.85
Effect of infusion air pressure on visual field defects after macular hole surgery. Am J Ophthalmol (2000) 1.85
Sp-1 binds promoter elements regulated by the RB protein and Sp-1-mediated transcription is stimulated by RB coexpression. Proc Natl Acad Sci U S A (1993) 1.84
Torpor in mice is induced by both leptin-dependent and -independent mechanisms. Proc Natl Acad Sci U S A (1999) 1.84
Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol (1998) 1.84
Dominant negative guard cell K+ channel mutants reduce inward-rectifying K+ currents and light-induced stomatal opening in arabidopsis. Plant Physiol (2001) 1.82
Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes. Br J Ophthalmol (1999) 1.80
Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor. Nature (1992) 1.80
Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. EMBO J (1999) 1.78
Mechanism of ergonovine-induced hyperconstriction of the large epicardial coronary artery in conscious dogs a month after arterial injury. Circ Res (1992) 1.78
An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res (1994) 1.77
Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest (1991) 1.75
Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J Biol Chem (1992) 1.75
Resistance to thyroid hormone. Rev Endocr Metab Disord (2000) 1.74
Identification of a Gs activator region of the beta 2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell (1991) 1.74
Microbial Conversion of alpha-Ionone, alpha-Methylionone, and alpha-Isomethylionone. Appl Environ Microbiol (1988) 1.72
Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem (2000) 1.72
Detection of new paternal dystrophin gene mutations in isolated cases of dystrophinopathy in females. Am J Hum Genet (1994) 1.70
An immunohistochemical study of developing glomeruli in human fetal kidneys. Kidney Int (2000) 1.69
Brief report: resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. N Engl J Med (1995) 1.68
Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin. Cancer Res (2000) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Study of four new kindreds with inherited thyroxine-binding globulin abnormalities. Possible mutations of a single gene locus. J Clin Invest (1972) 1.64
The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family. Blood (1998) 1.64
Occurrence of acid-labile sulfide in cadmium-binding peptide 1 from fission yeast. J Biochem (1983) 1.64
Structural basis for a Ca2+-sensing function of the metabotropic glutamate receptors. Science (1998) 1.63
Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner. J Neurosci (2001) 1.63
Continuing occurrence of thyroid carcinoma after irradiation to the neck in infancy and childhood. N Engl J Med (1975) 1.63
Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood (1997) 1.63
Clinical features of 53 cases with pustulotic arthro-osteitis. Ann Rheum Dis (1981) 1.62
Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol (2001) 1.61
Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group. Blood (2001) 1.61
Do the kinetics of peripheral muscle oxygenation reflect systemic oxygen intake? Eur J Appl Physiol (2001) 1.60
Thyroid hormone action on liver, heart, and energy expenditure in thyroid hormone receptor beta-deficient mice. Endocrinology (1998) 1.60
Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N Engl J Med (1991) 1.59
PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. Oncogene (2011) 1.59
Membrane protein molecular weight determined by low-angle laser light-scattering photometry coupled with high-performance gel chromatography. Methods Enzymol (1989) 1.59
Rapid localization of mutations in the thyroid hormone receptor-beta gene by denaturing gradient gel electrophoresis in 18 families with thyroid hormone resistance. J Clin Endocrinol Metab (1992) 1.58
Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res (1992) 1.57
Dapsone in the treatment of miliary lupus of the face. Br J Dermatol (1983) 1.57
Oral administration of the renal carcinogen, potassium bromate, specifically produces 8-hydroxydeoxyguanosine in rat target organ DNA. Carcinogenesis (1987) 1.57
Carcinoma of the ampulla of Vater: expression of cancer-associated antigens inversely correlated with prognosis. Am J Gastroenterol (1988) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J Biol Chem (1995) 1.55
The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1. Mol Cell Biol (1998) 1.55
Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia. Leuk Res (1999) 1.54
Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters. J Clin Endocrinol Metab (2000) 1.54
Molecular characterization of a new metabotropic glutamate receptor mGluR7 coupled to inhibitory cyclic AMP signal transduction. J Biol Chem (1994) 1.54
Genetic analysis reveals different functions for the products of the thyroid hormone receptor alpha locus. Mol Cell Biol (2001) 1.54
Thoracic epidural anesthesia attenuates halothane-induced myocardial sensitization to dysrhythmogenic effect of epinephrine in dogs. Anesthesiology (1995) 1.53
Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone. Mol Cell Biol (1997) 1.52
The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood (1997) 1.52
Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism. Hypertension (1997) 1.51
Coexisting thyroid and parathyroid disease--are they related? Surgery (1983) 1.51
hCDC47, a human member of the MCM family. Dissociation of the nucleus-bound form during S phase. J Biol Chem (1996) 1.51
Urokinase type plasminogen activator receptor expression in colorectal neoplasms. Gut (1998) 1.50
Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am J Pathol (1998) 1.49
Maximum stenosis of extracranial internal carotid artery: effect of luminal morphology on stenosis measurement by using CT angiography and conventional DSA. Radiology (2001) 1.49
Primary gastric T-cell lymphoma with and without human T-lymphotropic virus type 1. Cancer (1997) 1.49
Identification of two Sox17 messenger RNA isoforms, with and without the high mobility group box region, and their differential expression in mouse spermatogenesis. J Cell Biol (1996) 1.48
Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res (1999) 1.48
Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome. Hum Mol Genet (2001) 1.48
Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells. Am J Pathol (2001) 1.48